SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff

Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SARS‐CoV‐2 infection shortly after a first COVID‐1...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Doris Urlaub, Natalie Wolfsdorff, Deniz Durak, Frank Renken, Carsten Watzl
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	anti‐SARS‐CoV‐2 spike antibodies COVID‐19 SARS‐CoV‐2 vaccine Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/5902431511f448c2b60cff0972da2504
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5902431511f448c2b60cff0972da2504
record_format	dspace
spelling	oai:doaj.org-article:5902431511f448c2b60cff0972da25042021-11-12T19:57:15ZSARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff2050-452710.1002/iid3.525https://doaj.org/article/5902431511f448c2b60cff0972da25042021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.525https://doaj.org/toc/2050-4527Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SARS‐CoV‐2 infection shortly after a first COVID‐19 vaccine dose affects antibody responses. Methods Here we investigate residents and staff of a nursing home, where a COVID‐19 outbreak occurred shortly after the first BNT162b2 immunization. Results and Conclusions Our data show that individuals who got infected as early as 10 days after their first immunization show antibody levels comparable to fully vaccinated individuals.Doris UrlaubNatalie WolfsdorffDeniz DurakFrank RenkenCarsten WatzlWileyarticleanti‐SARS‐CoV‐2 spike antibodiesCOVID‐19SARS‐CoV‐2vaccineImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1702-1706 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	anti‐SARS‐CoV‐2 spike antibodies COVID‐19 SARS‐CoV‐2 vaccine Immunologic diseases. Allergy RC581-607
spellingShingle	anti‐SARS‐CoV‐2 spike antibodies COVID‐19 SARS‐CoV‐2 vaccine Immunologic diseases. Allergy RC581-607 Doris Urlaub Natalie Wolfsdorff Deniz Durak Frank Renken Carsten Watzl SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
description	Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SARS‐CoV‐2 infection shortly after a first COVID‐19 vaccine dose affects antibody responses. Methods Here we investigate residents and staff of a nursing home, where a COVID‐19 outbreak occurred shortly after the first BNT162b2 immunization. Results and Conclusions Our data show that individuals who got infected as early as 10 days after their first immunization show antibody levels comparable to fully vaccinated individuals.
format	article
author	Doris Urlaub Natalie Wolfsdorff Deniz Durak Frank Renken Carsten Watzl
author_facet	Doris Urlaub Natalie Wolfsdorff Deniz Durak Frank Renken Carsten Watzl
author_sort	Doris Urlaub
title	SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
title_short	SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
title_full	SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
title_fullStr	SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
title_full_unstemmed	SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
title_sort	sars‐cov‐2 infection shortly after bnt162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/5902431511f448c2b60cff0972da2504
work_keys_str_mv	AT dorisurlaub sarscov2infectionshortlyafterbnt162b2vaccinationresultsinhighantispikeantibodylevelsinnursinghomeresidentsandstaff AT nataliewolfsdorff sarscov2infectionshortlyafterbnt162b2vaccinationresultsinhighantispikeantibodylevelsinnursinghomeresidentsandstaff AT denizdurak sarscov2infectionshortlyafterbnt162b2vaccinationresultsinhighantispikeantibodylevelsinnursinghomeresidentsandstaff AT frankrenken sarscov2infectionshortlyafterbnt162b2vaccinationresultsinhighantispikeantibodylevelsinnursinghomeresidentsandstaff AT carstenwatzl sarscov2infectionshortlyafterbnt162b2vaccinationresultsinhighantispikeantibodylevelsinnursinghomeresidentsandstaff
_version_	1718430317745799168

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff

Ejemplares similares